| P2093 | author name string | Averell Gnatt | |
| | Antonino Passaniti | |
| | Alexander D MacKerell | |
| | Moran Choe | |
| | Jessica Bennett | |
| | David R D'Souza | |
| | Karen F Underwood | |
| | Bahru Habtemariam | |
| | Adam D Pierce | |
| | Maria Mochin-Peters | |
| | Sravya Kommineni | |
| P2860 | cites work | Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta | Q22254263 |
| | The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp | Q27630870 |
| | VMD: visual molecular dynamics | Q27860554 |
| | Cbfbeta interacts with Runx2 and has a critical role in bone development | Q28586662 |
| | DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition | Q29400901 |
| | Solvent-accessible surfaces of proteins and nucleic acids | Q29614464 |
| | A functional analysis of the CREB signaling pathway using HaloCHIP-chip and high throughput reporter assays | Q30876900 |
| | Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer | Q31943367 |
| | Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down | Q33513312 |
| | The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control | Q33670411 |
| | Vitamin D: metabolism | Q33888727 |
| | Development of a sensitive multi-well colorimetric assay for active NFkappaB | Q34233830 |
| | Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity | Q34739582 |
| | Vitamin D: marker or mechanism of action? | Q34779961 |
| | Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation | Q35638442 |
| | Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression | Q35779750 |
| | Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery | Q36062585 |
| | Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation | Q36329898 |
| | Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene | Q36550226 |
| | Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. | Q36682092 |
| | Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 |
| | Cyclin D1-cdk4 induce runx2 ubiquitination and degradation | Q37113937 |
| | Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway | Q37258582 |
| | HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching | Q38347789 |
| | Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation | Q39680824 |
| | The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation | Q40144929 |
| | Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells | Q40195895 |
| | Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation | Q40331133 |
| | Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells | Q40374373 |
| | Identification of novel extracellular signal-regulated kinase docking domain inhibitors. | Q40401482 |
| | Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway | Q40526648 |
| | Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. | Q40539678 |
| | Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling | Q40540364 |
| | Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells | Q40563055 |
| | Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31. | Q40904563 |
| | Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions | Q41902384 |
| | Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. | Q42826927 |
| | Receptor-DNA interactions: EMSA and footprinting | Q44828841 |
| | CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation. | Q45962907 |
| | Prediagnostic serum vitamin D and breast cancer | Q46780572 |
| | Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha. | Q52165310 |
| | An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3 and previtamin D3 | Q56087774 |
| | Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study | Q58231837 |
| P433 | issue | 4 | |
| P921 | main subject | cholecalciferol | Q139347 |
| P304 | page(s) | 913-925 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity | |
| P478 | volume | 27 | |